...
【24h】

Prognostic Significance of Hiatal Hernia in Patients with Gastric Cancer Located within the Upper-Third of the Stomach

机译:胃癌患者胃癌患者胃癌内三分之一内的预后意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Gastric cancers located within the upper-third of the stomach (UGC), especially the esophagogastric junction GC (EGJGC), have distinct clinicopathological features due to their potential for multidirectional lymphatic spread. In this study, we investigated the clinical significance of hiatal hernias (HH) in patients with UGC, including EGJGC. Methods In this retrospective study, we assessed status of HH in 147 patients with UGC who underwent curative resection at our hospital and examined the correlation between the presence of HH (+) and multiple clinicopathological factors. Results Thirty-four patients (23%) were HH (+). However, we found no significant correlation between HH (+) and clinicopathological factors. HH (+) patients frequently developed lymph node recurrences. Prognosis was significantly better in patients with UGC and HH (-), compared to those with UGC and HH (+). Similarly, EGJGC patients who were HH (-) showed superior survival compared to HH (+) patients. Multivariate analysis found that the HH (+) (p = 0.004), histological type (p = 0.029), and nodal stage (p = 0.034) were independent prognostic factors. Conclusions The presence of HH might affect lymphatic spread of tumor cells, and consequently prognosis of patients with UGC. Therefore, special attention is needed in developing surgical and postoperative strategies for such patients with UGC who are HH (+).
机译:背景技术位于胃中的上三分之一(UGC)的胃癌,尤其是食管胃部结GC(EGJGC),具有不同的临床病理特征,因为它们的多向淋巴蔓延的可能性。在这项研究中,我们研究了UGC患者HIATAL HERNIAS(HH)的临床意义,包括EGJGC。方法在该回顾性研究中,我们评估了147例UGC患者HH的状态,在我们医院进行治疗切除,检查HH(+)和多种临床病理因素之间的相关性。结果34名患者(23%)是HH(+)。然而,我们发现HH(+)和临床病理因素之间没有显着相关性。 HH(+)患者经常发生淋巴结复发。与UGC和HH(+)相比,UGC和HH( - )患者的预后显着更好。类似地,与HH( - )的EGJGC患者与HH(+)患者相比表现出优异的存活。多变量分析发现HH(+)(P = 0.004),组织学型(P = 0.029)和节点阶段(P = 0.034)是独立的预后因素。结论HH的存在可能会影响肿瘤细胞的淋巴蔓延,从而对UGC患者的预后。因此,在为HH(+)的UGC患者开发外科和术后策略时需要特别注意。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号